Lipiodol Localization for Ground-glass-opacity Minimal Surgery (LOGIS)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Consenting adult patients ≥ 20 years of age
- Pulmonary lesion with a ground glass opacity(GGO)component of more than 50%
- Patient with lesion size less than 3cm
- Persistence or growth of the established lesion within a three month period
- Patient who are not contraindicated to surgery
- Patients who are willing to sign the informed consent form
Exclusion criteria
- Patients with solid pulmonary lesion
- Patients with multiple GGOs need multiple localization
- Patients who are contraindicated to surgery
- Patients who behave in an uncooperative manner
- Unwilling or unable to give informed consent
- Pregnant women
Trial design
Primary purpose
Allocation
Interventional model
Masking
250 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal